SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (169)10/14/2001 8:18:53 PM
From: tuck  Respond to of 469
 
Nigel,

Nice dig. Tips me further in the direction of nibbling a little more in the single digits. OGSI has not rejoined the party this past week (as several BLUE H stocks -- less surprisingly -- also have not). This makes it relatively undervalued now, IMO, as I haven't noticed any missteps recently.

Cheers, Tuck



To: nigel bates who wrote (169)10/15/2001 10:50:08 AM
From: keokalani'nui  Read Replies (1) | Respond to of 469
 
If the "T-12" programme delivers on hype, the first OGS Mab candidate should hit the clinic end of 2002. Very nice confirming find.

Wilder


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News